Log In Sign up
The largest database of trusted experimental protocols

Ab16669

Manufactured by BioLegend
Visit Supplier

Ab16669 is a laboratory reagent designed for use in research applications. It is a primary antibody that can be used to detect and study specific proteins or other target molecules. The product specifications and technical details are available from the manufacturer, BioLegend, for researchers to review and determine if it meets the needs of their particular study or experiment.

Automatically generated - may contain errors

Lab products found in correlation

Polybrene, by Merck Group (2 mentions) Etoposide, by Merck Group (2 mentions) Puromycin, by Merck Group (2 mentions) 4 hydroxytamoxifen, by Merck Group (2 mentions) P p65 s536, by Cell Signaling Technology (2 mentions) P38 mapk inhibitor, by Selleck Chemicals (2 mentions) Af 400, by Active Motif (2 mentions) γ h2ax, by Abcam (2 mentions) Patm s1981, by Abcam (2 mentions) Recombinant human il1α protein, by R&D Systems (2 mentions) P p53 s15, by Cell Signaling Technology (2 mentions) Sting, by Cell Signaling Technology (2 mentions) Hygromycin, by Gemini Bio (2 mentions) Luciferin, by PerkinElmer (2 mentions)

2 protocols using ab16669

1

Innate Immunity and DNA Damage Response Pathway Analysis

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
Etoposide, 4-hydroxytamoxifen, puromycin, and polybrene were purchased from Sigma. Hygromycin was from Gemini Bio Products, and luciferin was from PerkinElmer. Recombinant human IL1α protein (used at 20 ng/ml) was from R&D Systems, and p38 MAPK inhibitor from Selleck Chemicals.
The following antibodies were described previously: Flag, p16, Lamin B1, GAPDH, and GFP5 (link). Other antibodies used include: γH2AX (Abcam #ab2893 and Cell Signaling Technology #9718), STING (Cell Signaling Technology #13647 and LSBio #LS-B7237), cGAS (Cell Signaling Technology #15102 and Santa Cruz Biotechnology #sc-245858), human IL1α (Abcam #ab9614), IL8 (Abcam #ab18672), p-ATM S1981 (Abcam #ab81292), p-p53 S15 (Cell Signaling Technology #9284), p-p65 S536 (Cell Signaling Technology #3033), p65 (Cell Signaling Technology 8242), NRas (Santa Cruz Biotechnology #sc-31), CD3 (Abcam #ab16669), Mac2 (BioLegend #125401), mouse IL1α (R&D Systems #AF-400), p21 (#sc-471), and H3 (Active Motif #39763).
Dou Z., Ghosh K., Vizioli M.G., Zhu J., Sen P., Wangensteen K.J., Simithy J., Lan Y., Lin Y., Zhou Z., Capell B.C., Xu C., Xu M., Kieckhaefer J.E., Jiang T., Shoshkes-Carmel M., Ahasan Al Tanim K.M., Barber G.N., Seykora J.T., Millar S.E., Kaestner K.H., Garcia B.A., Adams P.D, & Berger S.L. (2017). Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature, 550(7676), 402-406.
+ Open protocol
+ Expand
2

Innate Immunity and DNA Damage Response Pathway Analysis

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
Etoposide, 4-hydroxytamoxifen, puromycin, and polybrene were purchased from Sigma. Hygromycin was from Gemini Bio Products, and luciferin was from PerkinElmer. Recombinant human IL1α protein (used at 20 ng/ml) was from R&D Systems, and p38 MAPK inhibitor from Selleck Chemicals.
The following antibodies were described previously: Flag, p16, Lamin B1, GAPDH, and GFP5 (link). Other antibodies used include: γH2AX (Abcam #ab2893 and Cell Signaling Technology #9718), STING (Cell Signaling Technology #13647 and LSBio #LS-B7237), cGAS (Cell Signaling Technology #15102 and Santa Cruz Biotechnology #sc-245858), human IL1α (Abcam #ab9614), IL8 (Abcam #ab18672), p-ATM S1981 (Abcam #ab81292), p-p53 S15 (Cell Signaling Technology #9284), p-p65 S536 (Cell Signaling Technology #3033), p65 (Cell Signaling Technology 8242), NRas (Santa Cruz Biotechnology #sc-31), CD3 (Abcam #ab16669), Mac2 (BioLegend #125401), mouse IL1α (R&D Systems #AF-400), p21 (#sc-471), and H3 (Active Motif #39763).
Dou Z., Ghosh K., Vizioli M.G., Zhu J., Sen P., Wangensteen K.J., Simithy J., Lan Y., Lin Y., Zhou Z., Capell B.C., Xu C., Xu M., Kieckhaefer J.E., Jiang T., Shoshkes-Carmel M., Ahasan Al Tanim K.M., Barber G.N., Seykora J.T., Millar S.E., Kaestner K.H., Garcia B.A., Adams P.D, & Berger S.L. (2017). Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature, 550(7676), 402-406.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!